CLINICAL TRIALS PROFILE FOR CORTROSYN
✉ Email this page to a colleague
All Clinical Trials for CORTROSYN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00462644 ↗ | Evaluation of Etomidate on Adrenal Function in Trauma Patients | Completed | University of Tennessee | N/A | 2006-02-01 | Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients. |
| NCT00484679 ↗ | Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata | Completed | National Alopecia Areata Foundation | Phase 2 | 2007-05-01 | The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands. |
| NCT00484679 ↗ | Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata | Completed | University of Minnesota | Phase 2 | 2007-05-01 | The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands. |
| NCT00484679 ↗ | Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | 2007-05-01 | The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands. |
| NCT00817219 ↗ | Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris | Completed | LEO Pharma | Phase 2 | 2009-07-01 | The purpose of this study is to evaluate the safety and efficacy of 4 weeks of TACLONEX ointment in adolescent patients with psoriasis vulgaris. |
| NCT01421797 ↗ | Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation | Recruiting | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A | 2006-10-10 | Women with polycystic ovary syndrome (PCOS) often have irregular menstrual periods, too much facial and body hair, and weight gain. Women with PCOS also have a hard time becoming pregnant. Girls with high levels of the male hormone testosterone often develop PCOS as adults. Some girls with high levels of male hormone will develop normal hormone levels as they grow up, but most girls continue to have high levels of male hormone as adults. The purpose of this study is to understand where the male and female hormones come from in girls as they get older. The investigators think the adrenal gland, makes most of the hormones in young girls and that the ovary and the adrenal gland make these hormones in older girls. The investigators would like to find out whether an overactive adrenal gland makes these hormones higher in girls who are overweight, compared to those who are not overweight. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CORTROSYN
Condition Name
Clinical Trial Locations for CORTROSYN
Trials by Country
Clinical Trial Progress for CORTROSYN
Clinical Trial Phase
Clinical Trial Sponsors for CORTROSYN
Sponsor Name
| Sponsor Name for CORTROSYN | |
| Sponsor | Trials |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 1 |
| University of Minnesota - Clinical and Translational Science Institute | 1 |
| LEO Pharma | 1 |
| [disabled in preview] | 3 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
